J. Belliveau

482 total citations
10 papers, 389 citations indexed

About

J. Belliveau is a scholar working on Surgery, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, J. Belliveau has authored 10 papers receiving a total of 389 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Surgery, 3 papers in Oncology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in J. Belliveau's work include Chemotherapy-induced organ toxicity mitigation (2 papers), Laser-induced spectroscopy and plasma (2 papers) and Genomics and Rare Diseases (1 paper). J. Belliveau is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (2 papers), Laser-induced spectroscopy and plasma (2 papers) and Genomics and Rare Diseases (1 paper). J. Belliveau collaborates with scholars based in United States, Belgium and Germany. J. Belliveau's co-authors include E. A. de Bruijn, P. Schlag, W.J. Cunliffe, T. Graves, Richard E. Mullins, Paul H. Sugarbaker, Marshall R. Posner, William Vogel, A A Forastiere and Marshall P. Goren and has published in prestigious journals such as Toxicology, Applied Spectroscopy and Colorectal Disease.

In The Last Decade

J. Belliveau

10 papers receiving 366 citations

Peers

J. Belliveau

SURGE

ONCOL

PRM

RM

EM

Kaya Sarıbeyoğlu Türkiye

Enrico Maria Pasqual Italy

Chun‐Seok Yang South Korea

T Jastrzebski Poland

Anastasios Grivas Greece

Sylvie Demirdjian France

Annette Y. Sunga United States

F Cardì Italy

Valerie Francescutti United States

Alberto Vannelli Italy

Kaya Sarıbeyoğlu Türkiye

J. Belliveau

251 ×1.2

SURGE

55 ×0.5

ONCOL

75 ×0.8

PRM

13 ×0.2

RM

56 ×0.7

EM

Citations per year, relative to J. Belliveau J. Belliveau (= 1×) peers Kaya Sarıbeyoğlu

Countries citing papers authored by J. Belliveau

Since Specialization

Citations

This map shows the geographic impact of J. Belliveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Belliveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Belliveau more than expected).

Fields of papers citing papers by J. Belliveau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Belliveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Belliveau. The network helps show where J. Belliveau may publish in the future.

Co-authorship network of co-authors of J. Belliveau

This figure shows the co-authorship network connecting the top 25 collaborators of J. Belliveau. A scholar is included among the top collaborators of J. Belliveau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Belliveau. J. Belliveau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Belliveau, J., et al.. (2024). Expanding the phenotypic spectrum for CDK8‐related disease: A case report. American Journal of Medical Genetics Part A. 194(5). e63537–e63537. 1 indexed citations

2.

Wanebo, Harold J., et al.. (2003). Isolated chemotherapeutic perfusion of the pelvis for advanced rectal cancer. Colorectal Disease. 5(5). 508–514. 9 indexed citations

3.

Belliveau, J., et al.. (2002). Association of a gliotoxic activity with active multiple sclerosis in US patients.. PubMed. 48(2). 199–203. 3 indexed citations

4.

Sugarbaker, Paul H., W.J. Cunliffe, J. Belliveau, et al.. (1991). Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. PubMed. 16(4 Suppl 6). 272–275. 186 indexed citations

5.

Forastiere, A A, et al.. (1988). Pharmacokinetic and toxicity evaluation of five-day continuous infusion versus intermittent bolus cis-diamminedichloroplatinum(II) in head and neck cancer patients.. PubMed. 48(13). 3869–74. 70 indexed citations

6.

Posner, Marshall R., J. Belliveau, Alan B. Weitberg, et al.. (1987). Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.. PubMed. 71(10). 975–7. 8 indexed citations

7.

Belliveau, J., et al.. (1986). Cisplatin administered as a continuous 5-day infusion: plasma platinum levels and urine platinum excretion.. PubMed. 70(10). 1215–7. 49 indexed citations

8.

Belliveau, J., et al.. (1986). LIBS vs TRELIBS - The Relative Merits Of Laser-Induced Breakdown Spectroscopy Versus Time Resolved Laser-Induced Breakdown Spectroscopy. Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE. 644. 16–16. 4 indexed citations

9.

Belliveau, J., et al.. (1985). Laser-Induced Breakdown Spectroscopy of Steels at Atmospheric Pressure and in Air. Applied Spectroscopy. 39(4). 727–729. 27 indexed citations

10.

Sunderman, F. William, et al.. (1984). Effects of diethyldithiocarbamate and nickel chloride on glutathione and trace metal concentrations in rat liver. Toxicology. 32(1). 11–21. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact